Table of Contents


    Interventional Oncology Devices Market Report

    Subjects: Business
    View times: 0
    Submitted by: Dittya Sutar


    The rising government initiatives and the increasing preference for minimally invasive procedures are driving the demand for the market.

    The global Interventional Oncology Devices Market is forecasted to be worth USD 3.11 Billion by 2027, according to a current analysis by Emergen Research. Due to the increasing preference for minimally invasive treatments, the global Interventional Oncology Devices market is expected to proliferate. It is anticipated that increasing government initiatives to encourage Interventional Oncology will further boost the market growth. Besides, the rising technological advancements in the devices are also expected to augment the market growth.

    The Global  Interventional Oncology Devices Market report presents a comprehensive analysis of the  Interventional Oncology Devices market that offers valuable insights to the investors, stakeholders, and business strategists for the forecast period of 2020-2027. The report on the global  Interventional Oncology Devices market presents the expected growth rate and market value the market is expected to achieve in the coming years.

    The report also offers insightful data and recommendations to the market players, emerging players, and stakeholders on how to combat the COVID-19 pandemic. The report offers a comprehensive impact analysis of the pandemic on the  Interventional Oncology Devices market and its key segments. Furthermore, the report also covers a present and future impact analysis of the pandemic on market growth.

    Read more@

    Key Highlights From The Report

    In September 2020, The strategic investment in Nanospectra Biosciences, Inc. was announced by Sirtex Medical Limited. The investment will offer funding to improve further Nanospectra 's leading prostate cancer tissue ablation device AuroLase, the first and only ultra-focal ablation treatment intended to enhance the efficiency of treatment, reducing adverse effects related to anesthesia, chemotherapy, and alternate focal therapies. In order to destroy solid cancer tumors, this treatment uses the company's patented AuroShells nanoparticle technique to minimize the damage of neighboring healthy tissue.

    Over the forecasted timeline, the Embolization segment accounted for the largestmarket with a CAGR of 6.7%, since it is a minimally invasive therapy that offers advantages such as quick recovery, can be practiced through local anesthesia, and cost-effective.

    It is anticipated that Bland Embolization or Transcatheter Arterial Embolization will expand significantly. This method is being used for the treatment of liver tumors or for postsurgical adjunctive treatment.

    The segment of lung cancer will dominate the market during the forecasted period since smoking habits have increased the incidence of lung cancer.

    Due to the rising prevalence of cancer, easy availability of interventional oncology, and the fast adoption of technological advancement owing to significant government spending on medical treatment, the North American region is expected to dominate the market.

    Key participants include Sirtex Medical Limited, Teleflex Incorporated, Boston Scientific Corporation, INterface BIOmaterials B.V., Merit Medical Systems, Inc., BTG International Limited, IMBiotechnologies Ltd., IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.

    Request For Free Sample@

    Product Type Outlook (Revenue, USD Billion; 2017-2027)




    Process Outlook (Revenue, USD Billion; 2017-2027)

    Non-Thermal Tumor Ablation

    Thermal Tumor Ablation

    Transcatheter Arterial Radioembolization

    Transcatheter Arterial Chemoembolization

    Bland Embolization or Transcatheter Arterial Embolization

    Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

    Lung Cancer

    Liver Cancer

    Bone Cancer

    Breast Cancer

    Prostate Cancer

    Kidney Cancer


    Regional Outlook (Revenue, USD Billion; 2017-2027)

    North America


    Asia Pacific

    Latin America



    Table of Content


    Chapter 1. Methodology & Sources

        1.1. Interventional Oncology Devices Market Definition

        1.2. Interventional Oncology Devices Market Research Scope

        1.3. Interventional Oncology Devices Market Methodology

        1.4. Interventional Oncology Devices Market Research Sources

              1.4.1. Primary

              1.4.2. Secondary

              1.4.3. Paid Sources

       1.5. Interventional Oncology Devices Market Estimation Technique

    Chapter 2. Executive Summary

        2.1. Summary Snapshot, 2019-2027

    Chapter 3. Key Insights

    Chapter 4. Interventional Oncology Devices Market Segmentation & Impact Analysis



    Find similar reports by Emergen Research

    Medical Supplies Market  By Type, By Application (Urology, Wound Care, Radiology, Respiratory, Infection Control, Cardiology, IVD, Other Applications), By End User (Hospitals, Clinics, Others), and By Region, Forecasts to 2027

    Cloud Billing Market  By Component (Solution Services), By Billing Type, By Deployment Type (Private, Public), By Service Model (IaaS, PaaS, SaaS), By Organization Size (Large Enterprises, Small and Medium-Sized Enterprise), By Vertical, and By Region, Forecasts to 2027

    Nanopharmaceutical Drugs Market  By Type, By Application, By Distribution Channel, Forecasts to 2027

    Clinical Perinatal Software Market  By Product Type, By Deployment Mode, By Application, By End-User, Forecasts to 2027

    About Emergen Research

    At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

    Contact Us: Eric Lee






    1. Please check and comment entries here.